SAN CARLOS, Calif., Jan. 29 (HSMN NewsFeed) — Nektar Therapeutics (Nasdaq: NKTR ) announced today that Irwin Lerner has retired from its Board of Directors effective January 23, 2009. Mr. Lerner, former Chairman of Hoffmann-La Roche Inc., has been a mem…
Biopharmaceuticals, Personnel
Nektar Therapeutics

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Nektar Announces Retirement of Irwin Lerner from Board of Directors”
Leave a Comment